Clinical trial Ascent
An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan versus Treatment of Physician Choice in Patients with Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Immunomedics |
| EudraCT Identifier | 2017-003019-21 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03112174 |
| Inclusion criteria | 3rd line metastatic |
| Last update |